Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitragynine inhibits the COX-2 mRNA expression and prostaglandin E2 production induced by lipopolysaccharide in RAW264.7 macrophage cells
Zulkhurnain Utar, Mohamed Isa Abdul Majid, Mohd Ilham Adenan, et al.
Journal of Ethnopharmacology (2011) Vol. 136, Iss. 1, pp. 75-82
Closed Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction
Zurina Hassan, Muzaimi Mustapha, Visweswaran Navaratnam, et al.
Neuroscience & Biobehavioral Reviews (2012) Vol. 37, Iss. 2, pp. 138-151
Closed Access | Times Cited: 342
Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.
Walter C. Prozialeck, Jateen K Jivan, Shridhar V. Andurkar
PubMed (2012) Vol. 112, Iss. 12, pp. 792-9
Closed Access | Times Cited: 230
Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 194
Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
Abuse potential and adverse cognitive effects of mitragynine (kratom)
Nurul H.M. Yusoff, Farah Wahida Suhaimi, Raja Vadivelu, et al.
Addiction Biology (2014) Vol. 21, Iss. 1, pp. 98-110
Closed Access | Times Cited: 127
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine
Alicia G. Lydecker, Abhisheak Sharma, Christopher R. McCurdy, et al.
Journal of Medical Toxicology (2016) Vol. 12, Iss. 4, pp. 341-349
Open Access | Times Cited: 113
A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom
Paula N. Brown, Jensen A. Lund, Susan J. Murch
Journal of Ethnopharmacology (2017) Vol. 202, pp. 302-325
Closed Access | Times Cited: 107
Kratom policy: The challenge of balancing therapeutic potential with public safety
Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer, et al.
International Journal of Drug Policy (2019) Vol. 70, pp. 70-77
Open Access | Times Cited: 92
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 9
Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats
Azadeh Sabetghadam, Surash Ramanathan, Sreenivasan Sasidharan, et al.
Journal of Ethnopharmacology (2013) Vol. 146, Iss. 3, pp. 815-823
Closed Access | Times Cited: 79
Evaluation of the Cardiotoxicity of Mitragynine and Its Analogues Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Jun Lü, Heming Wei, Jian Wu, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e115648-e115648
Open Access | Times Cited: 67
Discriminative stimulus properties of mitragynine (kratom) in rats
Norsyifa Harun, Zurina Hassan, Visweswaran Navaratnam, et al.
Psychopharmacology (2015) Vol. 232, Iss. 13, pp. 2227-2238
Closed Access | Times Cited: 65
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Rahimah Hassan, Pike-See Cheah, Sreenivasan Sasidharan, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 61
Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60
Human disorders associated with inflammation and the evolving role of natural products to overcome
Navneet Kishore, Pradeep Kumar, Karuna Shanker, et al.
European Journal of Medicinal Chemistry (2019) Vol. 179, pp. 272-309
Closed Access | Times Cited: 56
An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells
Asep Bayu, Siti Irma Rahmawati, Firmansyah Karim, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1404-1404
Open Access | Times Cited: 8
Mitragynine Attenuates Withdrawal Syndrome in Morphine-Withdrawn Zebrafish
Beng-Siang Khor, Mohd Fadzly Amar Jamil, Mohamad Ilham Adenan, et al.
PLoS ONE (2011) Vol. 6, Iss. 12, pp. e28340-e28340
Open Access | Times Cited: 73
Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats
Nurul H.M. Yusoff, Sharif Mahsufi Mansor, Christian P. Müller, et al.
Behavioural Brain Research (2017) Vol. 332, pp. 1-6
Closed Access | Times Cited: 49
Piperine Inhibits the Activities of Platelet Cytosolic Phospholipase A2 and Thromboxane A2 Synthase without Affecting Cyclooxygenase-1 Activity: Different Mechanisms of Action Are Involved in the Inhibition of Platelet Aggregation and Macrophage Inflammatory Response
Dong Son, Satoshi Akiba, Jin Tae Hong, et al.
Nutrients (2014) Vol. 6, Iss. 8, pp. 3336-3352
Open Access | Times Cited: 43
Bioassay-guided isolation and mechanistic action of anti-inflammatory agents from Clerodendrum inerme leaves
Klaokwan Srisook, Ekaruth Srisook, Wenuka Nachaiyo, et al.
Journal of Ethnopharmacology (2015) Vol. 165, pp. 94-102
Closed Access | Times Cited: 43
Pharmacokinetics of mitragynine, a major analgesic alkaloid in kratom (Mitragyna speciosa): A systematic review
Kimheang Ya, Wimonchat Tangamornsuksan, C. Norman Scholfield, et al.
Asian Journal of Psychiatry (2019) Vol. 43, pp. 73-82
Closed Access | Times Cited: 42
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin
Alfredo Fabrizio Lo Faro, Annagiulia Di Trana, Nunzia La Maida, et al.
Journal of Pharmaceutical and Biomedical Analysis (2019) Vol. 179, pp. 112945-112945
Closed Access | Times Cited: 41
Mitragynine (Kratom) impairs spatial learning and hippocampal synaptic transmission in rats
Zurina Hassan, Farah Wahida Suhaimi, Surash Ramanathan, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 7, pp. 908-918
Open Access | Times Cited: 40
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples
Joana Gonçalves, Ângelo Luís, Eugénia Gallardo, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top